foxo4-dri peptide senolytic skin FOXO4-DRI: Human Trial Status, Cancer Research & Data foxo4-dri senolytic peptide human trials

Synthesis & Quality

Support for Insulin Sensitivity: It has shown potential in improving insulin sensitivity and addressing insulin resistance

A 2025 narrative review in Current Reviews in Musculoskeletal Medicine identified only three published human studies: Lee & Padgett (2021) on knee pain (n=16), Lee et al

While the initial effects may be felt shortly after the injection, B12 levels gradually decline over time, necessitating regular maintenance doses to sustain optimal levels

(Note: Chonluten is the EDG bronchopulmonary tripeptide it is not a cartilage or collagen extract, a confusion seen in one unreliable source.) Chonluten is not an approved medicine